AUS
NZ
UK
CA
USA
IND
Health
Institutional Shifts in Chemed Co. (NYSE:CHE) Amid Market Fluctuations
December 02, 2024 08:10 AM PST| By Team Kalkine MediaHighlights,Quantbot Technologies LP reduced its stake in Chemed by 77.6% in Q3.,Institutional investors own 95.85% of Chemed's shares.,Chemed’s stock recently traded at $572.39, reflecting market performance.,Chemed Corp , a prominent name in the hea...
Institutional Stake in Bausch Health Companies Inc. (NYSE:BHC)
November 29, 2024 09:20 AM PST| By Team Kalkine MediaHighlights,Bausch Health Companies Inc. is 56% owned by institutional shareholders.,Nine investors control 51% of the company’s shares.,Insiders hold 12% of Bausch Health Companies’ stock.,Bausch Health Companies Inc. operates as a significant play...
STERIS (NYSE:STE) Analyst Consensus and Market Performance Review
November 29, 2024 09:05 AM PST| By Team Kalkine MediaHighlights,STERIS holds an average “Moderate Buy” rating from six analysts.,Institutional investors control 94.69% of the company’s stock.,STERIS announced a quarterly dividend with a yield of 1.05%.,STERIS plc, a recognized player in the,NYSE Healt...
Newtopia Inc (NEWUF) Q3 2024 Earnings Call Emphasizes Strong Partnerships and Profitability
November 29, 2024 03:01 AM PST| By Team Kalkine MediaHighlights:,Newtopia Inc. forms a strategic partnership with a new supplemental insurance provider, introducing its habit change platform as a fully covered benefit in 2025.,The company secures key client renewals and expands contracts with major cli...
Evotec SE (NASDAQ: EVO) Announces Departure of Chief Operating Officer Dr. Craig Johnstone
November 29, 2024 12:08 AM PST| By Team Kalkine MediaHighlights:,Dr. Craig Johnstone to step down as COO effective December 31, 2024, after a 12-year tenure at Evotec.,Johnstone played a pivotal role in shaping Evotec's global operations and strategy since joining in 2012.,COO responsibilities will be...
Elanco Animal Health Faces Legal Action (NYSE:ELAN)
November 28, 2024 08:55 AM PST| By Team Kalkine MediaHighlights,-,Elanco hit with class action over drug claims.,-Misleading timelines for Zenrelia and Credelio Quattro.,-Lawsuit targets inflated commercialization expectations.,Elanco Animal Health, a prominent name in the healthcare industry, is embro...
Providence Capital Reduces Stake in Novartis (NYSE:NVS)
November 28, 2024 08:40 AM PST| By Team Kalkine MediaHighlights,-Providence Capital Cuts Novartis Stake,-Institutional Holdings Shift in Novartis,-Mixed Analyst Views on Novartis,Novartis AG ADR, a global leader in healthcare, has seen notable shifts in its institutional holdings. Recently, Providence...
Is Universal Health Services (NYSE:UHS) a Risky Investment?
November 27, 2024 09:40 AM PST| By Team Kalkine MediaHighlights,-UHS reduced debt from U$ 4.92B to US $ 4.66B.,-Debt-to-EBITDA ratio of 2.1 reflects responsible management.,-32% EBIT growth improves debt outlook.,Universal Health Services, a major,NYSE Healthcare Stocks,company, utilizes debt as part o...
STERIS plc (NYSE:STE) Sees Institutional Activity and Solid Earnings Growth
November 27, 2024 09:30 AM PST| By Team Kalkine MediaHighlights,-Citigroup Inc. decreases its stake in STERIS by 11% during Q3.,-STERIS’ Q3 earnings surpass analysts’ expectations with a 7.3% revenue increase.,-The company announces a quarterly dividend with a yield of 1.06%.,STERIS plc, a key player i...
Insulet Stock: Wall Street Analysts Weigh In on Possible Rise or Decline
November 27, 2024 02:49 AM PST| By Team Kalkine MediaHighlights:,Insulet Corporation (PODD), a leader in insulin delivery systems, has seen a 41.8% increase in its stock price over the past 52 weeks, outperforming the S&P 500 Index.,Despite strong performance in 2023, PODD's year-to-date (YTD) gain in...
Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) Advance 36% Despite Subdued Growth
November 27, 2024 02:41 AM PST| By Team Kalkine MediaHighlights:,ADMA Biologics (NASDAQ:ADMA) has experienced a significant 36% increase in its share price over the past month, contributing to a 458% gain over the last year.,The company’s price-to-sales (P/S) ratio of 13.3x is notably higher than the i...
Natixis Advisors LLC Enhances Stock Position in Alkermes plc (NASDAQ:ALKS)
November 27, 2024 01:30 AM PST| By Team Kalkine MediaHighlights:,Natixis Advisors LLC increased its stake in Alkermes plc by 190.3% in the third quarter, purchasing an additional 23,921 shares.,Institutional investors, including V Square Quantitative Management and GAMMA Investing, have been actively a...
Elevance Health's Strong Fundamentals Point to Future Growth Potential
November 26, 2024 05:36 PM PST| By Team Kalkine MediaHeadlines,Elevance Health's financial strength hints at potential long-term value.,A closer look at Return on Equity (ROE) reveals significant profitability.,Strong fundamentals may drive future growth despite recent stock performance.,Elevance Healt...
_11_26_2024_12_42_05_023014.jpg)
Molina Healthcare’s Strong Institutional Backing
November 26, 2024 09:35 AM PST| By Team Kalkine MediaHighlights,-Daiwa Securities Group Inc. increases its Molina Healthcare stake by 23.8%.,-Molina Healthcare’s quarterly revenue up 21% year-over-year.,-Institutional ownership of Molina Healthcare remains high, at 98.5%.,Molina Healthcare, Inc. is a p...
Exploring Owens & Minor’s Market Position & Analyst Sentiment
November 26, 2024 08:25 AM PST| By Team Kalkine MediaHighlights,-Owens & Minor gets a "Hold" rating from analysts.,-Institutional stakes see a boost in activity.,-Quarterly revenue rises 5%.,Wolfspeed saw its shares climb 8.5% after insider activity signaled confidence in the company’s future. Key stak...
Poseida Therapeutics Advances Gene and Cell Therapy Pipeline with Key Collaborations and Financial Growth
November 25, 2024 11:17 PM PST| By Team Kalkine MediaHighlights,Advances in Cancer and Gene Therapy,: Poseida Therapeutics is progressing in the development of,CAR-T therapies,for cancer and,gene therapies,for rare diseases,,Strategic Collaborations with Industry Leaders,: Poseida has formed,key partne...
Johnson & Johnson Shows Positive Momentum in Trading
November 25, 2024 05:34 PM PST| By Team Kalkine MediaHeadlines,Johnson & Johnson's stock gains traction with a recent 0.8% increase in mid-day trading.,Analysts maintain various outlooks, with multiple updated price targets showcasing confidence in JNJ's future.,New analyst ratings provide insight into...
ResMed's Strong Recent Performance and Long-Term Success
November 25, 2024 09:00 AM PST| By Team Kalkine MediaHighlights,-ResMed delivered a 71% total return over five years.,-EPS grew 21% annually, outpacing stock price gains.,-A 60% increase in share price last year signals strong growth.,ResMed Inc, a key player in the,NYSE Healthcare Stock,sector, has ha...
Key Metrics Driving Cencora’s Market Position
November 25, 2024 08:35 AM PST| By Team Kalkine MediaHighlights,-Analysts rate Cencora as Moderate Buy.,-Executives report significant share sales.,-Institutional ownership stands at 97.52%.,Cencora Inc. stands as a prominent player in the,NYSE Healthcare Stock,sector, delivering pharmaceutical distrib...
_11_25_2024_10_52_16_571753.jpg)
BorgWarner’s Impact on the Auto Industry
November 25, 2024 08:20 AM PST| By Team Kalkine MediaHighlight,-Target Price of $41.21 indicates moderate growth for BorgWarner Inc.,-BorgWarner maintains stable earnings despite challenges.,-Reliable dividend yield continues for BorgWarner shareholders.,BorgWarner Inc, a prominent name in the auto par...
